165 related articles for article (PubMed ID: 2864052)
1. Intrinsic sympathomimetic activity of cardioselective beta-adrenoceptor blockers and effects on renal function.
Mackay IG; Macnicol AM; Smith HJ; Cumming AD; Watson ML
Br J Clin Pharmacol; 1985 Sep; 20(3):197-203. PubMed ID: 2864052
[TBL] [Abstract][Full Text] [Related]
2. The effects of selective beta-adrenoceptor antagonists and partial agonist activity on renal function during exercise in normal subjects and those with moderate renal impairment.
Taverner D; Mackay IG; Craig K; Watson ML
Br J Clin Pharmacol; 1991 Sep; 32(3):387-91. PubMed ID: 1685667
[TBL] [Abstract][Full Text] [Related]
3. The effects of beta blockade with (epanolol) and without (atenolol) intrinsic sympathomimetic activity in stable angina pectoris. The Visacor Study Group.
Boberg J; Larsen FF; Pehrsson SK
Clin Cardiol; 1992 Aug; 15(8):591-5. PubMed ID: 1354086
[TBL] [Abstract][Full Text] [Related]
4. Beta blockers and renal function: a reappraisal.
Epstein M; Oster JR
J Clin Hypertens; 1985 Mar; 1(1):85-99. PubMed ID: 2873206
[TBL] [Abstract][Full Text] [Related]
5. Antihypertensive and hormonal responses to beta-blockade with intrinsic sympathomimetic activity: pindolol versus epanolol.
Simon G; Wittig VJ
J Cardiovasc Pharmacol; 1987 Nov; 10(5):543-7. PubMed ID: 2447403
[TBL] [Abstract][Full Text] [Related]
6. The effect of epanolol on intra-arterial ambulatory blood pressure and baroreceptor heart rate reflex in essential hypertension.
Smith SA; Littler WA
Clin Exp Pharmacol Physiol; 1988 Apr; 15(4):327-31. PubMed ID: 2908433
[TBL] [Abstract][Full Text] [Related]
7. Modest antihypertensive effect of epanolol, a beta 1-selective receptor blocker with beta 1 agonist activity: an acute and long-term hemodynamic study at rest and during exercise and double crossover comparison with atenolol on ambulatory blood pressure.
Omvik P; Lund-Johansen P; Haugland H
Cardiovasc Drugs Ther; 1993 Feb; 7(1):125-32. PubMed ID: 8097925
[TBL] [Abstract][Full Text] [Related]
8. Effects of beta-adrenoceptor blockade on heart rate and physiological tremor in diabetics with autonomic neuropathy. A comparative study of epanolol, atenolol and pindolol.
Reid W; Ewing DJ; Harry JD; Smith HJ; Neilson JM; Clarke BF
Br J Clin Pharmacol; 1987 Apr; 23(4):383-9. PubMed ID: 2883987
[TBL] [Abstract][Full Text] [Related]
9. Electrophysiological effects of cardioselective and non-cardioselective beta-adrenoceptor blockers with and without ISA at rest and during exercise.
Hombach V; Braun V; Höpp HW; Gil-Sanchez D; Behrenbeck DW; Tauchert M; Hilger HH
Br J Clin Pharmacol; 1982; 13(Suppl 2):285S-293S. PubMed ID: 6125178
[TBL] [Abstract][Full Text] [Related]
10. Effects of ICI 141,292 on exercise tachycardia and isoprenaline-induced beta-adrenoceptor responses in man.
Pringle TH; O'Connor PC; McNeill AJ; Finch MB; Riddell JG; Shanks RG
Br J Clin Pharmacol; 1986 Mar; 21(3):249-58. PubMed ID: 2870732
[TBL] [Abstract][Full Text] [Related]
11. Effects of epanolol, a selective beta1-blocker with intrinsic sympathomimetic activity, in patients with ischemic left ventricular dysfunction.
Van Den Heuvel AF; van der Ent M; van Veldhuisen DJ; Kruijssen DA; Bartels GL; Remme WJ
J Cardiovasc Pharmacol; 1998 Apr; 31(4):506-12. PubMed ID: 9554797
[TBL] [Abstract][Full Text] [Related]
12. Immediate haemodynamic effects of a novel partial agonist, beta 1-adrenoceptor blocking drug ICI 141,292 after intravenous administration to healthy young volunteers and patients with ischaemic heart disease.
Bonde J; Svendsen TL; Lyngborg K; Mehlsen J; Trap-Jensen J
Br J Clin Pharmacol; 1987 Jan; 23(1):35-40. PubMed ID: 2880603
[TBL] [Abstract][Full Text] [Related]
13. Beta-blockers and renal function.
Wilkinson R
Drugs; 1982 Mar; 23(3):195-206. PubMed ID: 6122552
[TBL] [Abstract][Full Text] [Related]
14. Cardiac and vascular beta-adrenoceptor-mediated responses before and during treatment with bisoprolol or atenolol.
Bolli P; Müller FB; Linder L; Ji BH; Bühler FR
J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S61-4. PubMed ID: 2439800
[TBL] [Abstract][Full Text] [Related]
15. Clinical pharmacology of epanolol. Pharmacodynamic aspects.
Harry JD
Drugs; 1989; 38 Suppl 2():18-27. PubMed ID: 2575976
[TBL] [Abstract][Full Text] [Related]
16. Peripheral vascular effects of beta-adrenoceptor blockade: comparison of two agents.
Cooke ED; Maltz MB; Smith RE; Bowcock SA; Watkins CJ; Camm AJ
Br J Clin Pharmacol; 1987 Sep; 24(3):359-66. PubMed ID: 2889459
[TBL] [Abstract][Full Text] [Related]
17. Investigation of possible pharmacokinetic and pharmacodynamic interactions between epanolol and digoxin.
Lefebvre RA; Bogaert MG; Duprez D
Eur J Clin Pharmacol; 1990; 38(5):505-7. PubMed ID: 1974206
[TBL] [Abstract][Full Text] [Related]
18. Post-exercise hypotension: the effects of epanolol or atenolol on some hormonal and cardiovascular variables in hypertensive men.
Wilcox RG; Bennett T; Macdonald IA; Broughton Pipkin F; Baylis PH
Br J Clin Pharmacol; 1987 Aug; 24(2):151-62. PubMed ID: 2887189
[TBL] [Abstract][Full Text] [Related]
19. The pharmacology of epanolol (ICI 141292)--a new beta 1-selective adrenoceptor partial agonist.
Bilski AJ; Hadfield SE; Wale JL
J Cardiovasc Pharmacol; 1988 Aug; 12(2):227-32. PubMed ID: 2459554
[TBL] [Abstract][Full Text] [Related]
20. Effect of atenolol on ventilatory and cardiac function in asthma.
Vilsvik JS; Schaanning J
Br Med J; 1976 Aug; 2(6033):453-5. PubMed ID: 8188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
